Skip to content

Clinical trials

Completed Diabetes Mellitus, Type 2 trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Completed Country / region: Serbia Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20064
20071
20081
20093
20105
20113
20126
20133
20143
20153
20166
20172
20181
20193
20201
20212
20223
20232
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S33
Gilead Sciences3
Takeda3
Boehringer Ingelheim2
Hoffmann-La Roche2
Sanofi2
University of Belgrade2
Aptabio Therapeutics, Inc.1
Daiichi Sankyo1
Genfit1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 256
Diabetes Mellitus26
Diabetic Nephropathies3
Glucose Metabolism Disorders3
Coronary Artery Disease2
Diabetes Mellitus, Type 12
Hyperglycemia2
Metabolic Diseases2
Acute Coronary Syndrome1
Angina Pectoris1

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.